Sera Prognostics Inc - Ordinary Shares Class A Stock, NASDAQ:SERA
2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109
United States of America
Number of Employees: 59
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.